Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Silvia, Quadrini"'
Autor:
Francesco Mannavola, Mario Mandala, Annalisa Todisco, Vanna Chiarion Sileni, Marco Palla, Alessandro Marco Minisini, Laura Pala, Francesca Morgese, Lorenza Di Guardo, Luigia Stefania Stucci, Michele Guida, Alice Indini, Pietro Quaglino, Virginia Ferraresi, Riccardo Marconcini, Maria Chiara Tronconi, Ernesto Rossi, Olga Nigro, Marcella Occelli, Alessio Cortellini, Silvia Quadrini, Giuseppe Palmieri, Jacopo Pigozzo, Paolo Antonio Ascierto, Maria Grazia Vitale, Sabino Strippoli, Pier Francesco Ferrucci, Rossana Berardi, Giovanni Randon, Pietro Cardone, Giovanni Schinzari, Franco Silvestris, Marco Tucci
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundWe performed a multicenter retrospective observational study to investigate the impact of clinical–pathological features and therapeutic strategies on both the complications and survival of patients with bone metastases (BMs) from maligna
Externí odkaz:
https://doaj.org/article/f7e6e5a9fa7d4cde857b7f04aa464c7d
Autor:
Gori, Maurizio Muscaritoli, Alessandra Modena, Matteo Valerio, Paolo Marchetti, Roberto Magarotto, Silvia Quadrini, Filomena Narducci, Giuseppe Tonini, Teresa Grassani, Luigi Cavanna, Camilla Di Nunzio, Chiara Citterio, Marcella Occelli, Antonia Strippoli, Bruno Chiurazzi, Antonio Frassoldati, Giuseppe Altavilla, Antonio Lucenti, Fabrizio Nicolis, Stefania
Publikováno v:
Cancers; Volume 15; Issue 12; Pages: 3206
Malnutrition affects up to 75% of cancer patients and results from a combination of anorexia and metabolic dysregulation. Metabolic and nutritional abnormalities in cancer patients can lead to cachexia, a multifactorial syndrome characterized by invo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::9da1f38c471cfea927383ed553fe72b5
Autor:
Luca Galli, Vincenzo Emanuele Chiuri, Giuseppe Di Lorenzo, Salvatore Pisconti, Sabrina Rossetti, Zuzana Sirotova, Andrea Muto, Roberto Petrioli, Michele De Tursi, Andrea Sbrana, Giulio Francolini, Antonio Ardizzoia, Claudio Scavelli, Francesco Satta, Silvia Quadrini, Mario Airoldi, Carmine D’Aniello, Andrea Bonetti, Serafino Conforti, Michele Aieta, Patrizia Beccaglia, Antonio Maestri, Lucia Fratino
Publikováno v:
Tumori Journal. 109:224-232
Background: With the availability of multiple treatment options for metastatic castration-resistant prostate cancer (mCRPC), new real-world data on disease management and drugs’ performance are needed. Methods: We described characteristics, managem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d275b343a042646594102378fc5ad4
https://doi.org/10.1177/03008916221079662
https://doi.org/10.1177/03008916221079662
Autor:
Giuseppina Rosaria Rita Ricciardi, Antonio Galvano, Francesco Pantano, Alain Gelibter, Michele Aieta, Daniele Santini, Marco Russano, Giulia Pasquini, Alessandro Russo, Lorenzo Calvetti, Giovanni Mansueto, Giuseppe Aprile, Giuseppe Tonini, Enrico Vasile, Sandro Barni, Marco Imperatori, Fausto Petrelli, Tindara Franchina, Michele Maio, Elisa Roca, Luana Calabrò, Maria Rita Migliorino, Daniela Iacono, Olga Martelli, Silvia Quadrini, Salvatore Intagliata, Vincenzo Adamo, Mario Occhipinti, Alfredo Falcone, Antonio Russo, Alfredo Berruti
Introduction: Immune checkpoint inhibitors have provided substantial benefit in non-small cell lung cancer (NSCLC) with unprecedented results in terms of survival. However, the identification of reliable predictive biomarkers to these agents is lacki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c230a8687a20374423c1bcc7d7f441
http://hdl.handle.net/11392/2492539
http://hdl.handle.net/11392/2492539
Autor:
Francesco Passiglia, Michele Aieta, Marco Imperatori, Giovanni Mansueto, Marco Russano, Alfredo Berruti, Giulia Pasquini, Daniele Santini, Elisa Roca, Tindara Franchina, Lorenzo Calvetti, Antonio Galvano, Anna Maria Di Giacomo, Iacopo Fioroni, Giuseppe Aprile, Daniela Iacono, Alessio Cortellini, Sandro Barni, Olga Martelli, Luana Calabrò, Michele Maio, Alain Gelibter, Maria Rita Migliorino, Bruno Vincenzi, Alessandro Russo, Corrado Ficorella, Olga Venditti, Silvia Quadrini, Salvatore Intagliata, Enrico Vasile, Giuseppe Tonini, Fausto Petrelli, Vincenzo Adamo, Alfredo Falcone, Mario Occhipinti, Antonio Russo, Andrea Napolitano, Francesco Pantano
Background: Immune-checkpoint inhibitors have radically changed the treatment landscape of Non-Small-Cell Lung Cancer (NSCLC). It is still unclear whether specific clinical characteristics might identify those patients benefiting from immunotherapy m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b5be2e8e2810f947ef83391c385b04
http://hdl.handle.net/11573/1484803
http://hdl.handle.net/11573/1484803
Autor:
Germano Zampa, Marcello Maugeri-Saccà, Silvia Quadrini, A. Vaccaro, Isabella Sperduti, Maddalena Barba, Patrizia Vici, Teresa Gamucci, Laura Pizzuti, Luca Moscetti, Lucia Mentuccia, Maria Agnese Fabbri, Domenico Sergi
Publikováno v:
Future Oncology. 13:1517-1525
Aim: Quality of life (QoL) is a critical issue for women with metastatic breast cancer (MBC). Eribulin mesylate represents a novel and active drug for pretreated MBC. Regretfully, few data exploring health-related (HR) QoL are available in unselected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec16e0879dd58a5c448437c38a51a72d
https://doi.org/10.2217/fon-2017-0062
https://doi.org/10.2217/fon-2017-0062
Autor:
Raffaella Bertè, Martina Valgiusti, Silvia Quadrini, Emanuela Scarpi, Elena Orlandi, Monia Dall'Agata, Alberto Farolfi, Andrea Casadei Gardini, Vittorina Zagonel, Ferdinando Garetto, Oriana Nanni, Marco Maltoni, Elena Amaducci, Chiara Broglia, Teresa Gamucci, Sara Alquati, Elisabetta Sansoni, Silvia Ruscelli, Romina Rossi, Daris Ferrari, Maria Simona Pino, Filomena Narducci, Silvia Stragliotto, Stefania Schiavon, Roberto Bortolussi, F. Negri
Purpose: Early palliative care (EPC) has shown a positive impact on quality of life (QoL), quality of care, and healthcare costs. We evaluated such effects in patients with advanced gastric cancer. Methods: In this prospective, multicenter study, 186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48603cb310ba8e447a36df1898b1722e
Autor:
Silvia Quadrini, Editta Baldini, Enrico Vasile, Francesco Grossi, Enrico Mini, Hector Soto Parra, Daniele Turci, Giovanni Luca Ceresoli, Marina Chiara Garassino, Stefano Cascinu, Carmelo Bengala, Gianpiero Fasola, Livio Blasi, Alain Gelibter, Carmine Pinto, Filippo de Marinis, Marianna Macerelli, Domenico Galetta, Rita Chiari, Diana Giannarelli, Francesco Cognetti, Paola Antonelli, Giuseppe Lo Russo
Introduction Nivolumab is the first checkpoint inhibitor approved for the treatment of nonsquamous NSCLC. We report results from the nivolumab Italian expanded access program focusing on never-smokers and patients with EGFR-mutant nonsqamous NSCLC. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54cec985ae23d54b6bf0557196c5765e
http://hdl.handle.net/20.500.11769/369763
http://hdl.handle.net/20.500.11769/369763
Autor:
Antonella Galiano, Stefania Schiavon, Massimo Luzzani, Monia Dall'Agata, Vittorina Zagonel, Irene Guglieri, Camilla Di Nunzio, Alfina Bramanti, Alberto Farolfi, Barbara Bocci, Maria Teresa Cattaneo, Andrea Casadei Gardini, Davide Dalu, Angela Ragazzini, Pietro Sozzi, Monica Bosco, Alice Giacobino, Luigi Cavanna, C. Gandini, Cataldo Mastromauro, F. Negri, Carla Codecà, Cristina Pittureri, Silvia Ruscelli, Oriana Nanni, Cristina Autelitano, Marco Maltoni, Luisa Fioretto, Augusto Caraceni, Sonia Zoccali, Giovanni Luca Frassineti, Emanuela Scarpi, Claudia Biasini, Giovanna Luchena, Ferdinando Garetto, Carla Longhi, Alberto Gozza, Luigi Montanari, Silvia Quadrini, Roberto Bortolussi, Monica Giordano, Chiara Broglia, Paolo Pedrazzoli, Angela Buonadonna, Alessandro Comandone, Sara Pini, Marina Faedi, Sara Alquati, Rodolfo Scognamiglio, Teresa Gamucci, Sara Lonardi, Elena Amaducci, Manlio Monti, Elisabetta Sansoni, Daris Ferrari, Maria Simona Pino, Francesca Bergamo, Daniela Degiovanni, Martina Valgiusti
Publikováno v:
European journal of cancer (Oxford, England : 1990). 72
The publisher regrets that the collaborators for this paper were not listed as such within the author details of the published paper. The collaborators were published in the Acknowledgements and are as follows: Alberto Farolfi, Silvia Ruscelli, Marti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511424c9d12309ff531c86688b423242
https://pubmed.ncbi.nlm.nih.gov/27821313
https://pubmed.ncbi.nlm.nih.gov/27821313
Autor:
Francesca Sperandi, Paola Antonelli, Diana Giannarelli, Filippo de Marinis, Silvia Quadrini, Paolo Bidoli, Daniele Turci, Milena Vitali, Luana Calabrò, Irene Prediletto, Anna Manzo, Angelo Delmonte, Marcello Tiseo, Lucio Crinò, Gabriele Minuti, Hector Soto Parra, Fabiana Vitiello, Francesco Grossi, Domenico Galetta, Simone Scagnoli
3067Background: Nivolumab is the first checkpoint inhibitor approved for the treatment of squamous non small cell lung cancer (Sq-NSCLC) to show a survival benefit in a randomised phase III trial. ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc39f5a4aace6d7da0858b6b6bf98389
http://hdl.handle.net/11585/733303
http://hdl.handle.net/11585/733303